WHO Sounds Alert Over Acute Lack of Weight-Loss Injections

Fewer than one in 10 people that would benefit from weight-loss injections including Wegovy are able to get them, caution the World Health Organization as it issues its initial recommendations on the therapies.

Given over a billion individuals worldwide currently living with obesity, it is urging increased and just access to this class of drugs.

According to forecasts, more than two billion are projected to be living with obesity by 2030 without intervention.

"The latest guidance recognises that excess weight is a long-term condition that can be addressed with comprehensive and continuous care," stated the agency's head Tedros Adhanom Ghebreyesus.

Substantial prices, constrained manufacturing, and logistical bottlenecks are significant obstacles to universal availability to the jabs that can aid individuals in losing considerable body mass, explains the agency.

GLP-1 Therapy Supply Crisis

Despite the current best projected outlook, the manufacturing of GLP-1 therapies would only suffice for approximately 100 million people – fewer than 10% of the global need, per the health organization.

The recommendation encourages nations and manufacturers to widen access, by strategies like licensing agreements.

The intellectual property rights on the active ingredient – the core component of the drug Wegovy – is due to expire in a number of nations in 2026.

How Weight-Loss Injections Operate

The injections imitate a body's own hormone to reduce digestion speed, curb appetite and boost satiety so users eat less.

Individuals typically begin shedding pounds within a few weeks of beginning the once-weekly jabs.

Evidence indicates users may regain a significant portion after a year of halting the medication, when their usual appetite return.

To be overweight or obese elevates your likelihood for contracting diseases, including diabetes, heart disease, stroke, and certain malignancies.

Obesity concerns people in every country and was associated with millions of fatalities worldwide in 2024, as per the WHO.